Skip to main content
. 2020 Sep 2;11:932. doi: 10.3389/fneur.2020.00932

Figure 3.

Figure 3

A conceivable therapeutic strategy for patients suspected of having optic neuritis. AQP4-IgG, anti-aquaporin-4 autoantibodies; CRAO, central retinal artery occlusion; CRVO, central retinal vein occlusion; DDx, differential diagnosis; HIV, human immunodeficiency virus; IVMP, intravenous methylprednisolone; MS, multiple sclerosis; MOG-IgG, anti-myelin oligodendrocyte glycoprotein antibody; ON, optic neuritis; STIR, short T1 inversion recovery; T1WI, T1-weighted imaging.